New major order from India

Bactiguard has received a new order from India of some 60 000 Foley catheters for infection prevention.

The initial order from India, which was received in December 2015, consisted of some 50 000 Foley catheters for infection prevention (BIP Foleys). The new order consists of some 60 000 BIP Foleys and will generate direct sales revenues of approximately 2 million SEK at product delivery.

“Sales and marketing activities in India are ongoing with a high level of intensity. There is a major need for infection prevention, as the level of multi resistant bacteria is high. Our products are now reaching hospitals and patients, where they are put to good use. As deliveries to dealers and hospitals are increasing, our distributor needs to restock its inventory, which is encouraging”, says Cecilia Edström, Vice President Sales & New Business.

This is information that Bactiguard Holding AB (publ) is required to publish in compliance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act. The information was submitted for publication on 10 August, 2016, at 08.00.

For further information, please contact:

Cecilia Edström, Vice President Sales & News business +46 72 226 23 28

About Bactiguard

Bactiguard is a Swedish medtech company with a global presence, offering a solution that prevents healthcare associated infections caused by medical devices. By preventing infections, we contribute to a reduced use of antibiotics and the spread of multi-resistant bacteria, which is a growing problem worldwide. We save lives, increase patient safety and significantly reduce the cost for the healthcare and society. Our technology is well-proven, safe and tissue friendly and consist of a thin layer of noble metals that prevents bacterial growth. The coating can be applied on almost all medical devices. Bactiguard-coated urinary catheters are market leading in the US and Japan and the company has also its own product portfolio consisting of Foley catheters, central venous catheters and endotracheal tubes. Bactiguard is a growth company, focused on markets in Europe, Middle East, Asia and Latin America. The company has about 60 employees worldwide, mainly at the headquarters in Stockholm and the production facility in Malaysia and is listed on Nasdaq Stockholm. Read more about Bactiguard at www.bactiguard.com